P279: Evaluating the utility of a new pathogenicity predictor for pediatric cardiomyopathy

• Alyssa Rippert,
• Sarah Trackman,
• Danielle Burstein,
• J. William Gaynor,
• Heather Griffis,
• Christine Seymour,
• Rebecca Ahrens-Nicklas

Affiliations

Alyssa Rippert

Division of Clinical Genetics, Children's Hospital of Philadelphia, Philadelphia, PA

Sarah Trackman

Rutgers University, New Brunswick, NJ

Danielle Burstein

The University of Vermont Medical Center, Burlington, VT

J. William Gaynor

Division of Cardiothoracic Surgery, Children's Hospital of Philadelphia, Philadelphia, PA

Heather Griffis

Center for Pediatric Clinical Effectiveness and PolicyLab, Children's Hospital of Philadelphia, PA

Christine Seymour

Rutgers University Genetic Counseling Master's Program, New Brunswick, NJ

Rebecca Ahrens-Nicklas

Division of Clinical Genetics, Children's Hospital of Philadelphia, Philadelphia, PA